Skip to content

Datenblatt ansehen

open_in_new
  1. Alles ansehen
  2. Polyclonal

GTX22248

Dysadherin antibody

Eine Lieferung in diese Region ist nicht möglich.

SKU:
GTX22248
Zusätzliche Namen:
FXYD domain containing ion transport regulator 5 , DYSAD , HSPC113 , IWU1 , KCT1 , OIT2 , PRO6241 , RIC
Anwendung:
WB
Konzentration:
0.50 mg/ml
Physischer Zustand:
Liquid
Spezies-Reaktivität:
Human
Aufreinigung:
Ammonium Sulfate Precipitated; Affinity Purified
Lagerbedingungen:
-20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
Hersteller:
Genetex
Host:
Goat
Reaktivitäten:
Human
Buffer:
TBS, 0.5% BSA, 0.02% Sodium azide.
Immunogen:
Peptide with sequence GKCRQLSRLCRNHCR, from the C Terminus of the protein sequence according to NP_054883.3; NP_659003.1; NP_001158077.1.
Uniprot:
Q96DB9
Synonyme:
DYSAD;dysadherin;FXYD domain-containing ion transport regulator 5;HSPC113;IWU1;KCT1;keratinocytes associated transmembrane protein 1;OIT2;PRO6241;RIC
Weitere Details:
This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. This gene product, FXYD5, is a glycoprotein that functions in the up-regulation of chemokine production, and it is involved in the reduction of cell adhesion via its ability to down-regulate E-cadherin. It also promotes metastasis, and has been linked to a variety of cancers. Alternative splicing results in multiple transcript variants. [RefSeq curation by Kathleen J. Sweadner, Ph.D., [email protected]., Sep 2009]
Versandbedingungen:
Blue Ice